BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25565775)

  • 1. Synthesis and characterization of a novel chemically designed (Globo)3-DTPA-KLH antigen.
    Hajmohammadi M; Siadat SD; Ghorbani M; Shafiee Ardestani M; Teimourian S; Asgari V; Ahangari Cohan R; Hajmohammadi M; Hajmohammadi A; Behzadi R; Rajab Nezhad S; Namvar Asl N
    Drug Des Devel Ther; 2015; 9():217-39. PubMed ID: 25565775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
    Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
    Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity study of Globo H analogues with modification at the reducing or nonreducing end of the tumor antigen.
    Lee HY; Chen CY; Tsai TI; Li ST; Lin KH; Cheng YY; Ren CT; Cheng TJ; Wu CY; Wong CH
    J Am Chem Soc; 2014 Dec; 136(48):16844-53. PubMed ID: 25371992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate.
    Kudryashov V; Ragupathi G; Kim IJ; Breimer ME; Danishefsky SJ; Livingston PO; Lloyd KO
    Glycoconj J; 1998 Mar; 15(3):243-9. PubMed ID: 9579801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of selected LeY and KH-1 analogues: a medicinal chemistry approach to vaccine optimization.
    Spassova MK; Bornmann WG; Ragupathi G; Sukenick G; Livingston PO; Danishefsky SJ
    J Org Chem; 2005 Apr; 70(9):3383-95. PubMed ID: 15844973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Globo-H cancer vaccine.
    Danishefsky SJ; Shue YK; Chang MN; Wong CH
    Acc Chem Res; 2015 Mar; 48(3):643-52. PubMed ID: 25665650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of widely consumed botanicals as immunological adjuvants.
    Ragupathi G; Yeung KS; Leung PC; Lee M; Lau CB; Vickers A; Hood C; Deng G; Cheung NK; Cassileth B; Livingston P
    Vaccine; 2008 Sep; 26(37):4860-5. PubMed ID: 18640165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
    Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
    J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens.
    Wang ZG; Williams LJ; Zhang XF; Zatorski A; Kudryashov V; Ragupathi G; Spassova M; Bornmann W; Slovin SF; Scher HI; Livingston PO; Lloyd KO; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2719-24. PubMed ID: 10716997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.
    Zhu J; Wan Q; Lee D; Yang G; Spassova MK; Ouerfelli O; Ragupathi G; Damani P; Livingston PO; Danishefsky SJ
    J Am Chem Soc; 2009 Jul; 131(26):9298-303. PubMed ID: 19518111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical total synthesis of globo-H for use in anticancer vaccines.
    Jeon I; Iyer K; Danishefsky SJ
    J Org Chem; 2009 Nov; 74(21):8452-5. PubMed ID: 19874068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.
    Wu J; Guo Z
    Bioconjug Chem; 2006; 17(6):1537-44. PubMed ID: 17105234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and vaccine evaluation of the tumor-associated carbohydrate antigen RM2 from prostate cancer.
    Chuang HY; Ren CT; Chao CA; Wu CY; Shivatare SS; Cheng TJ; Wu CY; Wong CH
    J Am Chem Soc; 2013 Jul; 135(30):11140-50. PubMed ID: 23819648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidates.
    Huo CX; Zheng XJ; Xiao A; Liu CC; Sun S; Lv Z; Ye XS
    Org Biomol Chem; 2015 Mar; 13(12):3677-90. PubMed ID: 25679360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of DHBcAg as a potent carrier protein comparable to KLH for augmenting MUC1 antigenicity.
    Gathuru JK; Koide F; Ragupathi G; Adams JL; Kerns RT; Coleman TP; Livingston PO
    Vaccine; 2005 Sep; 23(39):4727-33. PubMed ID: 15978705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21.
    Slovin SF; Ragupathi G; Fernandez C; Jefferson MP; Diani M; Wilton AS; Powell S; Spassova M; Reis C; Clausen H; Danishefsky S; Livingston P; Scher HI
    Vaccine; 2005 May; 23(24):3114-22. PubMed ID: 15837210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice.
    Zhang S; Graeber LA; Helling F; Ragupathi G; Adluri S; Lloyd KO; Livingston PO
    Cancer Res; 1996 Jul; 56(14):3315-9. PubMed ID: 8764127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of carbohydrate antigens for the preparation of vaccines for therapy in breast cancer.
    Croce MV; Segal-Eiras A
    Drugs Today (Barc); 2002 Nov; 38(11):759-68. PubMed ID: 12582459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
    Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
    ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis.
    Chang WW; Lee CH; Lee P; Lin J; Hsu CW; Hung JT; Lin JJ; Yu JC; Shao LE; Yu J; Wong CH; Yu AL
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11667-72. PubMed ID: 18685093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.